Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Ablynx    ABLX   BE0003877942

ABLYNX (ABLX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesNewsCalendarCompanyFinancialsRevisions 
Business Summary
Logo Ablynx
Develops and produces antibodies

Ablynx NV is a is a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand.

It includes hematology, inflammation, infectious disease, autoimmune disease, oncology, and immuno-oncology.

The company was founded on July 4, 2001 and is headquartered in Ghent, Belgium.
Managers
NameAgeSinceTitle
Edwin Moses, PhD642004Chief Executive Officer & Executive Director
Russell G. Greig, PhD662012Chairman
Wim Ottevaere622006Chief Financial Officer
Robert Freisen, PhD-2018Chief Scientific Officer
Remi Vermeiren782007Independent Non-Executive Director
William John Jenkins, MD712013Independent Non-Executive Director
Catherine Moukheibir, MBA592013Independent Non-Executive Director
Lutgart A. A. van den Berghe, PhD672015Independent Non-Executive Director
Hilde Windels532017Independent Non-Executive Director
Johan Heylen502014Chief Commercial Officer
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 78,001,392 676,916 0.9% 0 0.0% 0.9%
Markets and indexes
- Euronext Brussels
- Compartiment A
- Next Biotech / PEA
Stock Exchange Codes
- Bloomberg Code :  ABLX:BB
- Reuters Code :  ABLX.BR
- Datastream Code :  
Company contact information
Ablynx
Technologiepark 21
BE-9052 Zwijnaarde, Gent, Oost-Vlaanderen
Belgium

Phone : +32 (0)9 262 00 00
Fax : +32 (0)9 262 00 01
Internet : http://www.ablynx.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ABLYNX117.28%0
CELLTRION, INC.--.--%32 245
IQVIA HOLDINGS INC13.49%22 746
LONZA GROUP8.32%21 355
INCYTE CORPORATION-26.93%14 861
SEATTLE GENETICS, INC.31.33%11 158
ALNYLAM PHARMACEUTICALS, INC.-16.62%10 682
QIAGEN19.37%8 527
NEKTAR THERAPEUTICS-18.40%8 412
EXACT SCIENCES CORPORATION28.70%8 242
SAGE THERAPEUTICS INC2.34%7 844
ICON PLC24.96%7 442
ALKERMES PLC-17.71%7 020
PRA HEALTH SCIENCES INC12.57%6 485
CHARLES RIVER LABORATORIES INTL. INC13.54%5 851
BIO-TECHNE CORP20.74%5 782
IONIS PHARMACEUTICALS INC-7.55%5 754
UNITED THERAPEUTICS CORPORATION-15.49%5 403
GALAPAGOS15.65%5 399
GALAPAGOS NV (ADR)14.37%5 399
FIBROGEN INC37.24%5 379
Connections : Ablynx
Sanifit, Inc.
Apitope Technology (Bristol) Ltd.
Laboratoris Sanifit SL
Scottish Science Advisory Council
eTheRNA immunotherapies NV
Pro Vives Vzw
AlloCyte Pharmaceuticals AG
Mint Solutions Holding BV
AM-Pharma BV
Edinburgh BioQuarter
European Confederation of Directors Associations
GenKyoTex Suisse SA
University of Ghent
Belfius Bank SA/NV
Windels Hilde Bvba
Vlerick Leuven Gent Management School
Apitope International NV
William Jenkins Pharma Consulting
MedDay Pharmaceuticals SAS
Vlaams Instituut voor Biotechnologie - Flanders Institute
Creabilis Therapeutics SRL
FlandersBio vzw
© 2018 People , Fundamentals and Ownership
© 2018 Cofisem